Merck & Co., Inc. (NYSE:MRK) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. Reuters reported on ...

Trodelvy's latest setback carries implications for a newly important Merck drug, while the success of a once-weekly HIV ...

In two separate Phase 3 studies, the companies said a combination of islatravir and lenacapavir was not statistically inferior to the drug Biktarvy or standard-of-care treatments in patients with HIV.

Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing therapies across oncology, immunology, and diabetes and cardiovascular areas.

Add Yahoo as a preferred source to see more of our stories on Google. A wall showing a Merck & Co. logo in Kenilworth, New Jersey (Courtesy of Merck & Co.) This story was originally published on ...

A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of ...

Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

After years of lagging the market, healthcare may be taking on a new role in investor portfolios. Speaking on CNBC, Mizuho ...